KENNEDY CAPITAL MANAGEMENT LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 96 filers reported holding RECRO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2020$1,381,000
-63.4%
303,516
-34.3%
0.04%
-71.2%
Q1 2020$3,774,000
-52.0%
461,885
+7.6%
0.14%
-27.6%
Q4 2019$7,865,000
+62.8%
429,083
-1.6%
0.19%
+60.0%
Q3 2019$4,830,000
-5.1%
435,946
-12.8%
0.12%
-0.8%
Q2 2019$5,087,000
-27.4%
500,192
-58.2%
0.12%
+45.8%
Q1 2019$7,010,000
+97.2%
1,196,214
+138.9%
0.08%
-5.7%
Q4 2018$3,554,000
+103.1%
500,625
+103.4%
0.09%
+166.7%
Q3 2018$1,750,000
+40.7%
246,100
-0.7%
0.03%
+43.5%
Q2 2018$1,244,000247,8460.02%
Other shareholders
RECRO PHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders